Cheers to lighter, brighter & glowing skin
NICE guidance recommends reviewing GLP-1 therapy at 6 months, continuing only if HbA1c has reduced by at least 11 mmol/mol and weight has decreased by at least 3% of initial body weight for diabetes treatment
Clinics, including obesity and metabolic health centers, offer focused care with shorter wait times and more frequent patient follow-ups, which appeals to individuals seeking targeted weight loss treatments like GLP-1 therapies
This is a significant increase
Understanding hair loss on GLP-1s is important, but not as much as finding a practical solution
Rats with chronic compression SCI showed the most severe behavioral and electrophysiological dysfunction at 4 weeks after compression, with partial recovery at 8 weeks